Safety and Efficacy of Thymic Peptides in the Treatment of Hospitalized COVID-19 Patients in Honduras
Clinical trial NCT04771013 · COMPLETED
Trial details
- NCT number
- NCT04771013
- Sponsor
- Universidad Católica de Honduras
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-10
- Primary completion
- 2021-05-14
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.